Chinese vaccine trials in Brazil to resume after situation analysis by committee : Reports
Buenos Aires/Sputnik: Trials of the Chinese vaccine Coronavac in Brazil will resume after an analysis of the situation by a special committee, according to the G1 portal, which cited National Health Surveillance Agency ANVISA chief Antonio Torres.
Earlier, Anvisa temporarily halted tests of the Coronavac vaccine from the Sinovac laboratory in connection with a "serious incident" - due to the death of one of the volunteers.
"We need to be sent clear, accurate and complete documents, which has not happened," Torres said.
He also said that the agency had not been informed whether the cause of death was suicide. Information about that appeared in the media.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.